Nuts, metabolic syndrome and diabetes

British Journal of Nutrition

Volumn 104, Issue 4, 2010, Pages 465-473

  Kendall, Cyril W C ^a,b,c   Josse, Andrea R ^d   Esfahani, Amin ^a,b   Jenkins, David J A ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

CHD; Diabetes; Metabolic syndrome; Nuts

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CALCIUM; COPPER; CYANOCOBALAMIN; ESSENTIAL AMINO ACID; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; IRON; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; MANGANESE; MONOUNSATURATED FATTY ACID; NICOTINIC ACID; PANTOTHENIC ACID; PHOSPHORUS; PHYTOSTEROL; POLYUNSATURATED FATTY ACID; POTASSIUM; PYRIDOXINE; RETINOL; RIBOFLAVIN; SATURATED FATTY ACID; SELENIUM; SODIUM; THIAMINE; ZINC; LIPID;

ALMOND; BRAZIL NUT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASHEW NUT; DIABETES CONTROL; DIET THERAPY; FOOD COMPOSITION; FOOD INTAKE; GLYCEMIC CONTROL; GLYCEMIC INDEX; HAZELNUT; HUMAN; INSULIN SENSITIVITY; LIPID METABOLISM; MACADAMIA; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NUT; NUTRITIONAL VALUE; PECAN; PINE; PISTACHIO; REVIEW; RISK REDUCTION; TREATMENT OUTCOME; WALNUT; BLOOD; DIET; GLUCOSE BLOOD LEVEL; METABOLISM;

BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIET; HUMANS; LIPIDS; METABOLIC SYNDROME X; NUTRITIVE VALUE; NUTS;

EID: 77956211924     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114510001546     Document Type: Review

References (68)

1. International Diabetes Federation (2006) The IDF Consensus Worldwide Definition of the Metabolic Syndrome. Brussels: International Diabetes Federation.
2. Pradhan A (2007) Obesity, metabolic syndrome, and type 2 diabetes: Inflammatory basis of glucose metabolic disorders. Nutr Rev 65, S152-S156.
3. Shaw JE, Sicree RA & Zimmet PZ (2009) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract (Epublication ahead of print version).
4. Barrett-Connor E & Wingard DL (1983) Sex differential in ischemic heart disease mortality in diabetics: A prospective population-based study. Am J Epidemiol 118, 489-496.
5. Pan WH, Cedres LB, Liu K, et al. (1986) Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 123, 504-516.
6. Adeghate E, Schattner P & Dunn E (2006) An update on the etiology and epidemiology of diabetes mellitus. Ann N Y Acad Sci 1084, 1-29.
7. Kannel WB & McGee DL (1979) Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham study. Diabetes Care 2, 120-126.
8. Shichiri M, Kishikawa H, Ohkubo Y, et al. (2000) Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 23, Suppl. 2, B21-B29.
9. Stratton IM, Adler AI, Neil HA, et al. (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 321, 405-412.
10. Gaede P, Vedel P, Larsen N, et al. (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348, 383-393. (Pubitemid 36159355)
11. Laukkanen JA, Laaksonen DE, Niskanen L, et al. (2004) Metabolic syndrome and the risk of prostate cancer in Finnish men: A population-based study. Cancer Epidemiol Biomarkers Prev 13, 1646-1650.
12. American Diabetes Association (2007) Nutrition recommendations and interventions for diabetes: A position statement of the American Diabetes Association. Diabetes Care 30, Suppl. 1, S48-S65.
13. Giovannucci E (2007) Metabolic syndrome, hyperinsulinemia, and colon cancer: A review. Am J Clin Nutr 86, s836-s842.
14. Xue F & Michels KB (2007) Diabetes, metabolic syndrome, and breast cancer: A review of the current evidence. Am J Clin Nutr 86, s823-s835.
15. Shaffer EA (2006) Gallstone disease: Epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol 20, 981-996.
16. Pan XR, Li GW, Hu YH, et al. (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20, 537-544.
17. Tuomilehto J, Lindstrom J, Eriksson JG, et al. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344, 1343-1350. (Pubitemid 32378388)
18. Knowler WC, Barrett-Connor E, Fowler SE, et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346, 393-403.
19. Hu FB, Manson JE, Stampfer MJ, et al. (2001) Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345, 790-797.
20. Alberti KG, Zimmet P & Shaw J (2006) Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23, 469-480.
21. Phillips KM, Ruggio DM & Ashraf-Khorassani M (2005) Phytosterol composition of nuts and seeds commonly consumed in the United States. J Agric Food Chem 53, 9436-9445.
22. Segura R, Javierre C, Lizarraga MA, et al. (2006) Other relevant components of nuts: Phytosterols, folate and minerals. Br J Nutr 96, Suppl. 2, S36-S44.
23. US Department of Agriculture, Agricultural Research Service, Nutrient Data Laboratory, http://www.nal.usda.gov/fnic/food comp/search (accessed 12 January 2010).
24. Kris-Etherton PM, Hu FB, E Ros, et al. (2008) The role of tree nuts and peanuts in the prevention of coronary heart disease: Multiple potential mechanisms. J Nutr 138, 1746S-1751S.
25. Kris-Etherton PM, Zhao G, Binkoski AE, et al. (2001) The effects of nuts on coronary heart disease risk. Nutr Rev 59, 103-111.
26. Griel AE & Kris-Etherton PM (2006) Tree nuts and the lipid profile: A review of clinical studies. Br J Nutr 96, Suppl. 2, S68-S78.
27. Ros E (2009) Nuts and novel biomarkers of cardiovascular disease. Am J Clin Nutr 89, 1649S-1656S.
28. Estruch R, Martinez-Gonzalez MA, Corella D, et al. (2006) Effects of a Mediterranean-style diet on cardiovascular risk factors: A randomized trial. Ann Intern Med 145, 1-11.
29. Jenkins DJ, Kendall CW, Marchie A, et al. (2002) Dose response of almonds on coronary heart disease risk factors: Blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: A randomized, controlled, crossover trial. Circulation 106, 1327-1332.
30. Jenkins DJ, Kendall CW, Josse AR, et al. (2006) Almonds decrease postprandial glycemia, insulinemia, and oxidative damage in healthy individuals. J Nutr 136, 2987-2992.
31. Jiang R, Jacobs DR Jr, Mayer-Davis E, et al. (2006) Nut and seed consumption and inflammatory markers in the multi-ethnic study of atherosclerosis. Am J Epidemiol 163, 222-231.
32. Mukuddem-Petersen J, Oosthuizen W & Jerling JC (2005) A systematic review of the effects of nuts on blood lipid profiles in humans. J Nutr 135, 2082-2089.
33. Phung OJ, Makanji SS, White CM, et al. (2009) Almonds have a neutral effect on serum lipid profiles: A meta-analysis of randomized trials. J Am Diet Assoc 109, 865-873.
34. Banel DK & Hu FB (2009) Effects of walnut consumption on blood lipids and other cardiovascular risk factors: A meta-analysis and systematic review. Am J Clin Nutr 90, 56-63.
35. Sheridan MJ, Cooper JN, Erario M, et al. (2007) Pistachio nut consumption and serum lipid levels. J Am Coll Nutr 26, 141-148.
36. Kocyigit A, Koylu AA & Keles H (2006) Effects of pistachio nuts consumption on plasma lipid profile and oxidative status in healthy volunteers. Nutr Metab Cardiovasc Dis 16, 202-209.
37. Aksoy N, Aksoy M, Bagci C, et al. (2007) Pistachio intake increases high density lipoprotein levels and inhibits lowdensity lipoprotein oxidation in rats. Tohoku J Exp Med 212, 43-48.
38. Ternus M, McMahon K, Lapsley K, et al. (2006) Qualified health claim for nuts and heart disease prevention: Development of consumer-friendly language. Nutr Today 41, 62-66.
39. Jiang R, Manson JE, Stampfer MJ, et al. (2002) Nut and peanut butter consumption and risk of type 2 diabetes in women. JAMA 288, 2554-2560.
40. Parker ED, Harnack LJ & Folsom AR (2003) Nut consumption and risk of type 2 diabetes. JAMA 290, 38-39; author reply 39-40.
41. Hu FB, Stampfer MJ, Manson JE, et al. (1998) Frequent nut consumption and risk of coronary heart disease in women: Prospective cohort study. BMJ 317, 1341-1345.
42. Blomhoff R, Carlsen MH, Andersen LF, et al. (2006) Health benefits of nuts: Potential role of antioxidants. Br J Nutr 96, Suppl. 2, S52-S60.
43. Jenkins DJ, Wolever TM, Taylor RH, et al. (1981) Glycemic index of foods: A physiological basis for carbohydrate exchange. Am J Clin Nutr 34, 362-366.
44. Jenkins DJ, Kendall CW, McKeown-Eyssen G, et al. (2008) Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: A randomized trial. JAMA 300, 2742-2753.
45. International Diabetes Federation (2009) Guideline for Management of Postmeal Glucose. Brussels: International Diabetes Federation.
46. Josse AR, Kendall CW, Augustin LS, et al. (2007) Almonds and postprandial glycemia - a dose-response study. Metabolism 56, 400-404.
47. Garg A, Bonanome A, Grundy SM, et al. (1988) Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 319, 829-834.
48. Jonsson T, Granfeldt Y, Ahren B, et al. (2009) Beneficial effects of a paleolithic diet on cardiovascular risk factors in type 2 diabetes: A randomized cross-over pilot study. Cardiovasc Diabetol 8, 35.
49. Li TY, Brennan AM, Wedick NM, et al. (2009) Regular consumption of nuts is associated with a lower risk of cardiovascular disease in women with type 2 diabetes. J Nutr 139, 1333-1338.
50. Lovejoy JC, Most MM, Lefevre M, et al. (2002) Effect of diets enriched in almonds on insulin action and serum lipids in adults with normal glucose tolerance or type 2 diabetes. Am J Clin Nutr 76, 1000-1006.
51. Tapsell LC, Gillen LJ, Patch CS, et al. (2004) Including walnuts in a low-fat/modified-fat diet improves HDL cholesterol-to-total cholesterol ratios in patients with type 2 diabetes. Diabetes Care 27, 2777-2783.
52. Ma Y, Njike VY, Millet J, et al. (2010) Effects of walnut consumption on endothelial function in type 2 diabetic subjects: A randomized controlled crossover trial. Diabetes Care 33, 227-232.
53. Scott LW, Balasubramanyam A, Kimball KT, et al. (2003) Longterm, randomized clinical trial of two diets in the metabolic syndrome and type 2 diabetes. Diabetes Care 26, 2481-2482.
54. Tapsell LC, Batterham MJ, Teuss G, et al. (2009) Long-term effects of increased dietary polyunsaturated fat from walnuts on metabolic parameters in type II diabetes. Eur J Clin Nutr 63, 1008-1015.
55. Mukuddem-Petersen J, Stonehouse Oosthuizen W, Jerling JC, et al. (2007) Effects of a high walnut and high cashew nut diet on selected markers of the metabolic syndrome: A controlled feeding trial. Br J Nutr 97, 1144-1153. (Pubitemid 46925367)
56. Casas-Agustench P, Lopez-Uriarte P, Bullo M, et al. (2009) Effects of one serving of mixed nuts on serum lipids, insulin resistance and inflammatory markers in patients with the metabolic syndrome. Nutr Metab Cardiovasc Dis (Epublication ahead of print version 21 December 2009).
57. Pradhan AD & Ridker PM (2002) Do atherosclerosis and type 2 diabetes share a common inflammatory basis? Eur Heart J 23, 831-834.
58. Jenkins DJ, Kendall CW, Marchie A, et al. (2003) Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA 290, 502-510.
59. Larsson SC & Wolk A (2007) Magnesium intake and risk of type 2 diabetes: A meta-analysis. J Intern Med 262, 208-214. (Pubitemid 47087634)
60. Nissen SE & Wolski K (2007) Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356, 2457-2471.
61. Gerstein HC, Miller ME, Byington RP, et al. (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358, 2545-2559.
62. Patel A, MacMahon S, Chalmers J, et al. (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358, 2560-2572.
63. Bes-Rastrollo M, Wedick NM, Martinez-Gonzalez MA, et al. (2009) Prospective study of nut consumption, long-term weight change, and obesity risk inwomen. Am J Clin Nutr 89, 1913-1919.
64. Wien MA, Sabaté JM, Iklé DN, et al. (2003) Almonds vs complex carbohydrates in a weight reduction program. Int J Obes Relat Metab Disord 27, 1365-1372.
65. Ellis PR, Kendall CW, Ren Y, et al. (2004) Role of cell walls in the bioaccessibility of lipids in almond seeds. Am J Clin Nutr 80, 604-613.
66. Sacks FM, Bray GA, Carey VJ, et al. (2009) Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 360, 859-873.
67. Jenkins DJ, Wong JM, Kendall CW, et al. (2009) The effect of a plant-based low-carbohydrate ("Eco-Atkins") diet on body weight and blood lipid concentrations in hyperlipidemic subjects. Arch Intern Med 169, 1046-1054.
68. Dansinger ML, Gleason JA, Griffith JL, et al. (2005) Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: A randomized trial. JAMA 293, 43-53.